Literature DB >> 1917735

Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness.

P Bärtsch1, M Maggiorini, W Schobersberger, S Shaw, W Rascher, J Girard, P Weidmann, O Oelz.   

Abstract

A possible contribution of exercise to the fluid retention associated with acute mountain sickness (AMS) was investigated in 17 mountaineers who underwent an exercise test for 30 min on a bicycle ergometer with a constant work load of 148 +/- 9 (SE) W at low altitude (LA) and with 103 +/- 6 W 4-7 h after arrival at 4,559 m or high altitude (HA). Mean heart rates during exercise at both altitudes and during active ascent to HA were similar. Exercise-induced changes at LA did not differ significantly between the eight subjects who stayed well and the nine subjects who developed AMS during a 3-day sojourn at 4,559 m. At HA, O2 saturation before (71 +/- 2 vs. 83 +/- 2%, P less than 0.01) and during exercise (67 +/- 2 vs. 72 +/- 1%, P less than 0.025) was lower and exercise-induced increase of plasma aldosterone (617 +/- 116 vs. 233 +/- 42 pmol/l, P less than 0.025) and plasma antidiuretic hormone (23.8 +/- 14.4 vs. 3.4 +/- 1.8 pmol/l, P less than 0.05) was greater in the AMS group, whereas exercise-induced rise of plasma atrial natriuretic factor and changes of hematocrit, potassium, and osmolality in plasma were similar in both groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917735     DOI: 10.1152/jappl.1991.71.1.136

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  The effect of hypohydration severity on the physiological, psychological and renal hormonal responses to hypoxic exercise.

Authors:  Alan Richardson; Peter Watt; Neil Maxwell
Journal:  Eur J Appl Physiol       Date:  2009-02-06       Impact factor: 3.078

2.  Renal reactivity: acid-base compensation during incremental ascent to high altitude.

Authors:  Shaelynn M Zouboules; Hailey C Lafave; Ken D O'Halloran; Tom D Brutsaert; Heidi E Nysten; Cassandra E Nysten; Craig D Steinback; Mingma T Sherpa; Trevor A Day
Journal:  J Physiol       Date:  2018-10-28       Impact factor: 5.182

Review 3.  Medicine and mechanisms in altitude sickness. Recommendations.

Authors:  J H Coote
Journal:  Sports Med       Date:  1995-09       Impact factor: 11.136

4.  Treatment of acute mountain sickness by simulated descent: a randomised controlled trial.

Authors:  P Bärtsch; B Merki; D Hofstetter; M Maggiorini; B Kayser; O Oelz
Journal:  BMJ       Date:  1993-04-24

5.  Resting arterial oxygen saturation and breathing frequency as predictors for acute mountain sickness development: a prospective cohort study.

Authors:  Martin Faulhaber; Maria Wille; Hannes Gatterer; Dieter Heinrich; Martin Burtscher
Journal:  Sleep Breath       Date:  2014-01-17       Impact factor: 2.816

Review 6.  Short-term responses of the kidney to high altitude in mountain climbers.

Authors:  Alexander S Goldfarb-Rumyantzev; Seth L Alper
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

7.  Angiotensin-converting enzyme genotype and arterial oxygen saturation at high altitude in Peruvian Quechua.

Authors:  Abigail W Bigham; Melisa Kiyamu; Fabiola León-Velarde; Esteban J Parra; Maria Rivera-Ch; Mark D Shriver; Tom D Brutsaert
Journal:  High Alt Med Biol       Date:  2008       Impact factor: 1.981

8.  Copeptin and arginine vasopressin at high altitude: relationship to plasma osmolality and perceived exertion.

Authors:  A J Mellor; C J Boos; S Ball; A Burnett; S Pattman; M Redpath; D R Woods
Journal:  Eur J Appl Physiol       Date:  2014-09-12       Impact factor: 3.078

Review 9.  Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia.

Authors:  Priya Gaur; Supriya Saini; Praveen Vats; Bhuvnesh Kumar
Journal:  Endocrine       Date:  2018-01-30       Impact factor: 3.633

10.  Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia.

Authors:  Jim Hansen; Mikael Sander
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.